Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2026-01-17 @ 1:14 PM
Study NCT ID:
NCT05093504
Status:
TERMINATED
Last Update Posted:
2025-05-04
First Post:
2021-10-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D)
Sponsor:
CytoSorbents, Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-27
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-29
Completion Date Type:
ACTUAL
First Submit Date:
2021-10-01
First Submit QC Date:
None
Study First Post Date:
2021-10-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-03-24
Results First Submit QC Date:
None
Results First Post Date:
2025-05-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-17
Last Update Post Date:
2025-05-04
Last Update Post Date Type:
ACTUAL